Department of Obstetrics and Gynecology, Faculty of Medicine, Panyananthaphikkhu Chonprathan Medical Center, Srinakharinwirot University, Nonthaburi, Thailand.
National Cancer Institute, Department of Medical Services, Ministry of Public Health, Bangkok, Thailand.
Int J Gynaecol Obstet. 2021 Jan;152(1):48-52. doi: 10.1002/ijgo.13481.
Cervical cancer is the third most common cancer among Thai women, after breast and colon cancer, with an age-standardized incidence rate (ASR) of 11.7/100 000 women each year, as of 2015. Over decades, comprehensive national cervical cancer screening programs, research, and the HPV vaccination policy have gradually helped decrease the incidence of cervical cancer in Thailand. In 2017, the Thai Ministry of Public Health signed a memorandum of understanding with the Royal Thai College of Obstetricians and Gynecologists to eliminate invasive cervical cancer from Thailand. This is a tremendous challenge for Thailand as a whole. The present paper reviews and discusses the experiences in the prevention and screening of cervical cancer in Thailand.
在泰国女性中，宫颈癌是第三大常见癌症，仅次于乳腺癌和结肠癌，2015 年年龄标准化发病率（ASR）为每年每 10 万名女性 11.7 人。几十年来，全面的国家宫颈癌筛查计划、研究和 HPV 疫苗接种政策逐渐帮助降低了泰国宫颈癌的发病率。2017 年，泰国公共卫生部与泰国妇产科皇家学院签署了一份谅解备忘录，旨在消除泰国的浸润性宫颈癌。这对整个泰国来说是一个巨大的挑战。本文回顾和讨论了泰国在宫颈癌预防和筛查方面的经验。
